Imax rode a pair of male-skewing blockbusters in Paramount's "Gladiator II" and Sony's "Venom: The Last Dance," plus holiday audiences for Disney's "Mufasa" to a strong $93 million in revenue for Q4 of 2024.

Overall quarterly revenue was $92.7 million, up 8 percent from a year-earlier $86 million, as ‘Gladiator II,’ ‘Venom: The Last Dance’ and ‘Mufasa: The Lion King’ played on its screens.

Imax provides its patented technology to theaters around the world, which means new signings mean almost as much to its bottom line as ticket sales. In 2024, Imax installed 146 new systems worldwide. This year, Imax said it expects to have new system installations of 145 to 160.

Imax shared an 8% year-over-year increase but it missed Wall Street projections for $104 million in quarterly revenue.